These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The physical dimensions of amyloid aggregates control their infective potential as prion particles. Marchante R, Beal DM, Koloteva-Levine N, Purton TJ, Tuite MF, Xue WF. Elife; 2017 Sep 07; 6():. PubMed ID: 28880146 [Abstract] [Full Text] [Related]
13. Conformational variations in an infectious protein determine prion strain differences. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Nature; 2004 Mar 18; 428(6980):323-8. PubMed ID: 15029196 [Abstract] [Full Text] [Related]
14. Nucleation seed size determines amyloid clearance and establishes a barrier to prion appearance in yeast. Villali J, Dark J, Brechtel TM, Pei F, Sindi SS, Serio TR. Nat Struct Mol Biol; 2020 Jun 18; 27(6):540-549. PubMed ID: 32367069 [Abstract] [Full Text] [Related]
15. Temperature dependence of the aggregation kinetics of Sup35 and Ure2p yeast prions. Sabaté R, Villar-Piqué A, Espargaró A, Ventura S. Biomacromolecules; 2012 Feb 13; 13(2):474-83. PubMed ID: 22176525 [Abstract] [Full Text] [Related]
16. [Dynamics of in vitro amyloid fiber formation of yeast prion protein Sup35NM]. Wei HY, Liu YX, Wang JW, Qu JG, Zhao WM, Yu XP, Hong T. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar 13; 20(1):39-42. PubMed ID: 16642217 [Abstract] [Full Text] [Related]
17. Hsp40 function in yeast prion propagation: Amyloid diversity necessitates chaperone functional complexity. Sporn ZA, Hines JK. Prion; 2015 Mar 13; 9(2):80-9. PubMed ID: 25738774 [Abstract] [Full Text] [Related]